Literature DB >> 20096637

Parameters for establishing humanized mouse models to study human immunity: analysis of human hematopoietic stem cell engraftment in three immunodeficient strains of mice bearing the IL2rgamma(null) mutation.

Michael A Brehm1, Amy Cuthbert, Chaoxing Yang, David M Miller, Philip DiIorio, Joseph Laning, Lisa Burzenski, Bruce Gott, Oded Foreman, Anoop Kavirayani, Mary Herlihy, Aldo A Rossini, Leonard D Shultz, Dale L Greiner.   

Abstract

"Humanized" mouse models created by engraftment of immunodeficient mice with human hematolymphoid cells or tissues are an emerging technology with broad appeal across multiple biomedical disciplines. However, investigators wishing to utilize humanized mice with engrafted functional human immune systems are faced with a myriad of variables to consider. In this study, we analyze HSC engraftment methodologies using three immunodeficient mouse strains harboring the IL2rgamma(null) mutation; NOD-scid IL2rgamma(null), NOD-Rag1(null) IL2rgamma(null), and BALB/c-Rag1(null) IL2rgamma(null) mice. Strategies compared engraftment of human HSC derived from umbilical cord blood following intravenous injection into adult mice and intracardiac and intrahepatic injection into newborn mice. We observed that newborn recipients exhibited enhanced engraftment as compared to adult recipients. Irrespective of the protocol or age of recipient, both immunodeficient NOD strains support enhanced hematopoietic cell engraftment as compared to the BALB/c strain. Our data define key parameters for establishing humanized mouse models to study human immunity. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20096637      PMCID: PMC2835837          DOI: 10.1016/j.clim.2009.12.008

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  41 in total

1.  NOD/LtSz-Rag1nullPfpnull mice: a new model system with increased levels of human peripheral leukocyte and hematopoietic stem-cell engraftment.

Authors:  Leonard D Shultz; Scott Banuelos; Bonnie Lyons; Rebecca Samuels; Lisa Burzenski; Bruce Gott; Pamela Lang; Jean Leif; Michael Appel; Aldo Rossini; Dale L Greiner
Journal:  Transplantation       Date:  2003-10-15       Impact factor: 4.939

2.  Development of a human adaptive immune system in cord blood cell-transplanted mice.

Authors:  Elisabetta Traggiai; Laurie Chicha; Luca Mazzucchelli; Lucio Bronz; Jean-Claude Piffaretti; Antonio Lanzavecchia; Markus G Manz
Journal:  Science       Date:  2004-04-02       Impact factor: 47.728

3.  Competitive repopulation assay of two gene-marked cord blood units in NOD/SCID/gammac(null) mice.

Authors:  Takashi Yahata; Kiyoshi Ando; Hiroko Miyatake; Tomoko Uno; Tadayuki Sato; Mamoru Ito; Shunichi Kato; Tomomitsu Hotta
Journal:  Mol Ther       Date:  2004-11       Impact factor: 11.454

4.  An assay for long-term engrafting human hematopoietic cells based on newborn NOD/SCID/beta2-microglobulin(null) mice.

Authors:  Fumihiko Ishikawa; Anne G Livingston; John R Wingard; Shin ichi Nishikawa; Makio Ogawa
Journal:  Exp Hematol       Date:  2002-05       Impact factor: 3.084

5.  NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells.

Authors:  Mamoru Ito; Hidefumi Hiramatsu; Kimio Kobayashi; Kazutomo Suzue; Mariko Kawahata; Kyoji Hioki; Yoshito Ueyama; Yoshio Koyanagi; Kazuo Sugamura; Kohichiro Tsuji; Toshio Heike; Tatsutoshi Nakahata
Journal:  Blood       Date:  2002-11-01       Impact factor: 22.113

Review 6.  Mechanism of human stem cell migration and repopulation of NOD/SCID and B2mnull NOD/SCID mice. The role of SDF-1/CXCR4 interactions.

Authors:  T Lapidot
Journal:  Ann N Y Acad Sci       Date:  2001-06       Impact factor: 5.691

7.  NOD/LtSz-Rag1null mice: an immunodeficient and radioresistant model for engraftment of human hematolymphoid cells, HIV infection, and adoptive transfer of NOD mouse diabetogenic T cells.

Authors:  L D Shultz; P A Lang; S W Christianson; B Gott; B Lyons; S Umeda; E Leiter; R Hesselton; E J Wagar; J H Leif; O Kollet; T Lapidot; D L Greiner
Journal:  J Immunol       Date:  2000-03-01       Impact factor: 5.422

Review 8.  Humanized mice for the study of type 1 diabetes and beta cell function.

Authors:  Marie King; Todd Pearson; Aldo A Rossini; Leonard D Shultz; Dale L Greiner
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

9.  A new xenograft model for graft-versus-host disease by intravenous transfer of human peripheral blood mononuclear cells in RAG2-/- gammac-/- double-mutant mice.

Authors:  Rozemarijn S van Rijn; Elles R Simonetti; Anton Hagenbeek; Marieke C H Hogenes; Roel A de Weger; Marijke R Canninga-van Dijk; Kees Weijer; Hergen Spits; Gert Storm; Louis van Bloois; Ger Rijkers; Anton C M Martens; Saskia B Ebeling
Journal:  Blood       Date:  2003-06-05       Impact factor: 22.113

10.  Non-obese diabetic-recombination activating gene-1 (NOD-Rag1 null) interleukin (IL)-2 receptor common gamma chain (IL2r gamma null) null mice: a radioresistant model for human lymphohaematopoietic engraftment.

Authors:  T Pearson; L D Shultz; D Miller; M King; J Laning; W Fodor; A Cuthbert; L Burzenski; B Gott; B Lyons; O Foreman; A A Rossini; D L Greiner
Journal:  Clin Exp Immunol       Date:  2008-09-08       Impact factor: 4.330

View more
  126 in total

Review 1.  HIV-1 immunopathogenesis in humanized mouse models.

Authors:  Liguo Zhang; Lishan Su
Journal:  Cell Mol Immunol       Date:  2012-04-16       Impact factor: 11.530

Review 2.  Rodent models for HIV-associated neurocognitive disorders.

Authors:  Santhi Gorantla; Larisa Poluektova; Howard E Gendelman
Journal:  Trends Neurosci       Date:  2012-02-01       Impact factor: 13.837

3.  Membrane-bound human SCF/KL promotes in vivo human hematopoietic engraftment and myeloid differentiation.

Authors:  Shinsuke Takagi; Yoriko Saito; Atsushi Hijikata; Satoshi Tanaka; Takashi Watanabe; Takanori Hasegawa; Shinobu Mochizuki; Jun Kunisawa; Hiroshi Kiyono; Haruhiko Koseki; Osamu Ohara; Takashi Saito; Shuichi Taniguchi; Leonard D Shultz; Fumihiko Ishikawa
Journal:  Blood       Date:  2012-01-25       Impact factor: 22.113

4.  An update on the use of NOD mice to study autoimmune (Type 1) diabetes.

Authors:  Rodolfo José Chaparro; Teresa P Dilorenzo
Journal:  Expert Rev Clin Immunol       Date:  2010-11       Impact factor: 4.473

5.  Immunodeficient mouse model for human hematopoietic stem cell engraftment and immune system development.

Authors:  Ken-Edwin Aryee; Leonard D Shultz; Michael A Brehm
Journal:  Methods Mol Biol       Date:  2014

6.  Insufficient interleukin-12 signalling favours differentiation of human CD4(+) and CD8(+) T cells into GATA-3(+) and GATA-3(+) T-bet(+) subsets in humanized mice.

Authors:  Eva Billerbeck; Rachael N Labitt; Kevin Vega; Natalia Frias-Staheli; Marcus Dorner; Jing W Xiao; Charles M Rice; Alexander Ploss
Journal:  Immunology       Date:  2014-10       Impact factor: 7.397

7.  Long term human reconstitution and immune aging in NOD-Rag (-)-γ chain (-) mice.

Authors:  David T Harris; Michael Badowski
Journal:  Immunobiology       Date:  2013-09-05       Impact factor: 3.144

8.  Mice engrafted with human hematopoietic stem cells support a human myeloid cell inflammatory response in vivo.

Authors:  Andrew Baird; Chenliang Deng; Matthew H Eliceiri; Fatima Haghi; Xitong Dang; Raul Coimbra; Todd W Costantini; Bruce E Torbett; Brian P Eliceiri
Journal:  Wound Repair Regen       Date:  2016-10-04       Impact factor: 3.617

9.  Human immune system development and rejection of human islet allografts in spontaneously diabetic NOD-Rag1null IL2rgammanull Ins2Akita mice.

Authors:  Michael A Brehm; Rita Bortell; Philip Diiorio; Jean Leif; Joseph Laning; Amy Cuthbert; Chaoxing Yang; Mary Herlihy; Lisa Burzenski; Bruce Gott; Oded Foreman; Alvin C Powers; Dale L Greiner; Leonard D Shultz
Journal:  Diabetes       Date:  2010-06-22       Impact factor: 9.461

10.  Human antigen-specific regulatory T cells generated by T cell receptor gene transfer.

Authors:  Todd M Brusko; Richard C Koya; Shirley Zhu; Michael R Lee; Amy L Putnam; Stephanie A McClymont; Michael I Nishimura; Shuhong Han; Lung-Ji Chang; Mark A Atkinson; Antoni Ribas; Jeffrey A Bluestone
Journal:  PLoS One       Date:  2010-07-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.